Stocks to watch on August 6: Aurobindo Pharma, Hindalco, PB Fintech, Mindspace REIT in focus as Q1 results and key developments unfold; GIFT NIFTY hints at positive open
Ramesh NairHindalco IndustriesUSFDATrent Ltd.PB FintechPaschim Gujarat Vij CompanyHero MotoCorpPolicyBazaarLICAditya Birla GroupNovelisAurobindo PharmaMindspace Business Parks REITBritannia Industries

Stocks to watch on August 6: Aurobindo Pharma, Hindalco, PB Fintech, Mindspace REIT in focus as Q1 results and key developments unfold; GIFT NIFTY hints at positive open

Stocks to watch on August 6 include Aurobindo Pharma, Hindalco, PB Fintech, and Mindspace REIT, as they report Q1 results. GIFT NIFTY indicates a positive opening, with Hindalco's earnings and PB Fintech's 92% profit rise drawing attention, alongside Mindspace's 28% NOI increase.

Moneycontrol.com+1 source6 August 2026 · 03:23 UTC
CuriousCats Full Story

Stocks to watch on August 6 include Aurobindo Pharma, Hindalco, PB Fintech, and Mindspace REIT, as they prepare to unveil their Q1 results amidst a backdrop of positive market indicators.23

The GIFT NIFTY futures suggest a promising start for the NIFTY50 index, indicating an opening 47 points higher.4

Hindalco Industries, a key player in the metals sector, is expected to attract attention following the earnings report of its subsidiary, Novelis, for the June quarter (Q1 FY27).

Meanwhile, PB Fintech, which operates PolicyBazaar, reported a remarkable 92% year-on-year increase in consolidated net profit, reaching ₹163 crore in Q1 FY27, up from ₹85 crore in the same quarter last year.

Mindspace Business Parks REIT also reported strong performance, with a 28% increase in net operating income (NOI) to ₹788 crore for the quarter ended June, alongside a distribution of ₹442 crore to unitholders.

Ramesh Nair, MD and CEO of Mindspace REIT, stated, “We delivered year-on-year NOI growth of 27.8 per cent and a distribution of ₹6.67 per unit, up 15.2% over the prior year.”

Key Insight
“Aurobindo Pharma received a Form FDA 483 with five observations from a USFDA inspection of its Hyderabad facility, none related to data integrity. RMC Switchgears secured orders worth ₹344.10 crore, including 12 LoAs from PGVCL for turnkey contracts.”
Shilpa Medicare Reports Strong Q1 Earnings | CNBC TV18
CuriousCats Shorts-list
Shilpa Medicare Reports Strong Q1 Earnings | CNBC TV18
CuriousCats studied:
1
Moneycontrol.com
“The United States Food and Drug Administration (USFDA) conducted an inspection of the company's manufacturing facility in Pashamylaram, Hyderabad, from July 27 to August 5, 2026. Following the inspection, the company received a Form FDA 483 containing five observations. None of the observations relate to data integrity issues.”
Moneycontrol.com →
2
Upstox
“The GIFT NIFTY futures suggest that the NIFTY50 index will open 47 points higher.”
Upstox →
Ask CuriousCats
What did Aurobindo Pharma's inspection reveal?
How much did RMC Switchgears secure in orders?
Why is GIFT NIFTY significant today?
Are other pharmaceutical companies facing inspections?
How do Aurobindo Pharma's observations compare to past issues?
Get your CIA-level briefing,
in real time.
CuriousCats monitors the internet every minute for you and brings you the most personalized brief of videos, social media posts, news and more.
Download the App
Liked the depth here?
Get the full internet briefed for you any time of the day.
Get CuriousCats